Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
AKRO - STOCK-BASED COMPENSATION
Stock-based Compensation AKRO - Akero Therapeutics, Inc.
21.5 M
LAST VALUE
46.22%
2 YEAR CAGR
181.79%
5 YEAR CAGR
0.00%
10 YEAR CAGR